Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Peptivo vs Ryze Rx

Peptivo
Graded #330

Higher grade

vs+1.8999999999999986
Ryze Rx
Graded #376

Lower grade

The verdict

Peptivo takes it — 60.1/100 to 58.2/100, but only just.

Peptivo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Peptivo is a 100% online GLP-1 weight-loss telehealth service offering compounded medication made in the USA at FDA-registered labs, with same-day provider visits and 24/7 messaging. Ryze Rx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePeptivo +1
45
44
Dose & formulationRyze Rx +11
53
64
Clinical oversightPeptivo +1
76
75
Labs & monitoringPeptivo +13
65
52
FulfillmentPeptivo +5
74
69
Contract termsPeptivo +14
55
41
Peptivo · left barRyze Rx · right bar

The numbers

MetricPeptivoRyze Rx
WeighScore60.1/10058.2/100
GradeCC
Scorecard rank#330#376
SemaglutideNot disclosed$199/mo (starting dose, 3 month plan, compounded)
TirzepatideNot disclosed$199/mo (starting dose, 3 month plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Peptivo

Graded #330 · C

Strengths

  • Low entry pricing — GLP-1 weight-loss plans starting at $169/mo, with free discreet shipping
  • Same-day provider visits and 24/7 provider messaging; 100% online
  • Compounded in the USA at FDA-registered labs; can also prescribe brand GLP-1 (Ozempic, Wegovy, Zepbound)
  • FSA/HSA eligible with upfront pricing

Where it loses points

  • GLP-1 products use generic names ('GLP-1 Daily Support', 'Weight Loss Boost') — semaglutide/tirzepatide not clearly broken out
  • Compounding pharmacy/lab partner not named
  • Limited published policies (privacy and terms only; no HIPAA notice or refund policy found)
  • Not LegitScript-certified (no certification displayed)
Ryze Rx

Graded #376 · C

Strengths

  • Compounded semaglutide and tirzepatide both $199/mo, with $499/$799 three-month bundles
  • Physician consultation, ongoing clinical support and discreet shipping included with each prescription
  • Broad catalog beyond GLP-1: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide and more)
  • Free shipping, 24hr prescription turnaround, FSA/HSA eligible; care advertised in all 50 states

Where it loses points

  • Terms, Privacy Policy and HIPAA notice are dead links - no legal entity, refund policy or governing law disclosed
  • Pharmacy partners not named - only 'US-licensed compounding pharmacies'
  • Homepage advertises GLP-1s 'from $149/mo' but the catalog lists $199/mo
  • On-site '4.9/5, 2,400+ reviews' is self-reported, not an independently verified rating

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard